H

Heron Therapeutics
D

HRTX

1.07500
USD
0.03
(2.38%)
Market Closed
Volume
32,279
EPS
-2
Div Yield
-
P/E
-7
Market Cap
163,502,030
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    More
News

Title: Heron Therapeutics

Sector: Healthcare
Industry: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.